Table 1

Characteristics of the 134 patients and relation to relapse-free survival

No. of patients (%)Relapse-free survival
No. of eventsaPb
AgeNS
 H5041 (30.6)12
 >5093 (69.4)36
Menopausal statusNS
 Premenopausal47 (35.1)16
 Postmenopausal87 (64.9)32
Histological gradecNS
 I18 (14.4)5
 II60 (48.0)25
 III47 (37.6)17
Lymph node status<0.05
 Node-negative50 (37.3)10
 Node-positive84 (62.7)38
Estrogen receptor statusNS
 +(≥10 fm/mg)89 (66.4)34
 −(<10 fm/mg)45 (33.6)14
Progesterone receptor statusNS
 +(≥10 fm/mg)79 (59.0)28
 −(<10 fm/mg)55 (41.0)20
Macroscopic tumor sizedNS
 H30 mm93 (73.2)33
 >30 mm34 (26.8)13
  • a First relapses (local and/or regional recurrences, and/or metastases).

  • b Log-rank test. NS, not significant.

  • c Scarff Bloom Richardson classification. Information is available for 125 patients.

  • d Information is available for 127 patients.